Home › Funds › Monaco Asset Management SAM › VNDA

Monaco Asset Management SAM position in VNDA

VANDA PHARMACEUTICALS INC · Health Care

Monaco Asset Management SAM reported holding 236,286 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.2M, representing 0.17% of its reported portfolio and ranking #31 among its reported holdings. Monaco Asset Management SAM has disclosed VNDA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)236.29K sh
Reported value held$1.16M
Portfolio Weight0.17%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Monaco Asset Management SAM's VNDA position evolved

Monaco Asset Management SAM first disclosed a stake in VNDA in Q3 2023 at 135,000 shares (US$583K). The position peaked in Q4 2024 at 392,262 shares, worth US$1.9M. Across 12 filings, Monaco Asset Management SAM increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 236,286 shares valued at US$1.2M — an increase of 15,000 shares quarter over quarter.. Notable position changes include a 37% trim in Q4 2023 (shares fell 3% over the following quarter), a 93% increase in Q4 2024 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 135.00K $583.20K New
Q4 2023 85.00K $358.70K Reduce
Q2 2024 192.93K $1.09M New
Q3 2024 203.43K $954.07K Add
Q4 2024 392.26K $1.88M Add
Q1 2025 325.00K $1.49M Reduce
Q2 2025 305.00K $1.44M Reduce
Q3 2025 247.81K $1.24M Reduce
Q4 2025 196.29K $1.73M Reduce
Q1 2026 241.29K $1.67M Add
Q2 2026 221.29K $1.35M Reduce
Q3 2026 236.29K $1.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VNDA and 13F data

VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VNDA — the largest reported positions include Siren, L.L.C. (US$38.4M), AIGH Capital Management LLC (US$11.0M), Krensavage Asset Management, LLC (US$7.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VNDA

All VNDA fund holders →

FAQ

How long has Monaco Asset Management SAM held VNDA?

Monaco Asset Management SAM has disclosed VNDA holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Monaco Asset Management SAM's current position in VNDA?

As of Q3 2026, Monaco Asset Management SAM holds 236.29K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $1.16M, representing 0.17% of its reported portfolio and ranking #31.

Has Monaco Asset Management SAM been buying or selling VNDA?

In the latest 13F filing (Q3 2026), Monaco Asset Management SAM increased its position in VNDA. The position peaked in Q4 2024 at 392.26K shares.

Which other funds hold VNDA?

Other major institutional holders of VNDA include Siren, L.L.C., AIGH Capital Management LLC, Krensavage Asset Management, LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.